Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E C, Tufekci"'
Publikováno v:
European journal of gynaecological oncology. 37(6)
To investigate the predictive value of the Risk of Malignancy Index (RMI), CA-125, and inflammatory markers in discriminating ovarian cancers (OCs).The postmenopausal (PM) women (n= 139) with adnexal masses who un- derwent surgery were included. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0c5e6d42b39808fe28bb7d2defa7f9a
https://pubmed.ncbi.nlm.nih.gov/29943934
https://pubmed.ncbi.nlm.nih.gov/29943934
WOS: 000237935100007
PubMed ID: 16698659
Objective Risedronate is a bisphosphonate used in the treatment of osteoporosis. It has a strong effect in inhibiting osteoclast activity. The primary objective of this study was to evaluate the effe
PubMed ID: 16698659
Objective Risedronate is a bisphosphonate used in the treatment of osteoporosis. It has a strong effect in inhibiting osteoclast activity. The primary objective of this study was to evaluate the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31353c48ec37ec9db1cf9402bb94de34
https://hdl.handle.net/20.500.12415/7301
https://hdl.handle.net/20.500.12415/7301
Publikováno v:
Climacteric. Apr2006, Vol. 9 Issue 2, p129-134. 6p. 1 Diagram, 3 Charts.
Autor:
Park, Jin, Byun, Youngro
Publikováno v:
Archives of Pharmacal Research; Dec2014, Vol. 37 Issue 12, p1560-1569, 10p